ANTIFUNGAL THERAPY - POTENTIAL INTERACTIONS WITH OTHER CLASSES OF DRUGS

被引:31
作者
BICKERS, DR
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,SKIN DIS RES CTR,CLEVELAND,OH
[2] UNIV CLEVELAND HOSP,CLEVELAND,OH 44106
关键词
D O I
10.1016/S0190-9622(08)81276-5
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Combination drug therapy is widely used for the management of many common medical conditions. The concurrent use of more than one drug can significantly alter the therapeutic and side-effect profile of each individual agent. Such drug-drug interactions are generally classified either as pharmacokinetic or pharmacodynamic. Oral agents used for the management of superficial fungal infections can have both types of interactions. This article describes common drug-drug interactions observed with amphotericin B, flucytosine, griseofulvin, ketoconazole, fluconazole, and itraconazole.
引用
收藏
页码:S87 / S90
页数:4
相关论文
共 18 条
[1]   COMPARISON OF AMPHOTERICIN-B ALONE AND COMBINED WITH FLUCYTOSINE IN THE TREATMENT OF CRYPTOCCAL MENINGITIS [J].
BENNETT, JE ;
DISMUKES, WE ;
DUMA, RJ ;
MEDOFF, G ;
SANDE, MA ;
GALLIS, H ;
LEONARD, J ;
FIELDS, BT ;
BRADSHAW, M ;
HAYWOOD, H ;
MCGEE, ZA ;
CATE, TR ;
COBBS, CG ;
WARNER, JF ;
ALLING, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (03) :126-131
[2]   DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANS [J].
BRASS, C ;
GALGIANI, JN ;
BLASCHKE, TF ;
DEFELICE, R ;
OREILLY, RA ;
STEVENS, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :151-158
[3]  
CHREN M-M, 1990, P1572
[4]  
CHUNG DK, 1971, AM REV RESPIR DIS, V103, P831
[5]  
CIARNCROSS KD, 1965, ARCH INT PHARMACOD T, V154, P438
[6]  
DAANESHMEND TK, 1982, LANCET, V2, P1342
[7]  
HERDEMANN HT, 1983, AM J MED, V75, P476
[8]   TERFENADINE-KETOCONAZOLE INTERACTION - PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CONSEQUENCES [J].
HONIG, PK ;
WORTHAM, DC ;
ZAMANI, K ;
CONNER, DP ;
MULLIN, JC ;
CANTILENA, LR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (12) :1513-1518
[9]  
JOHNSTON RR, 1976, ANESTH ANALG, V55, P709
[10]   PNEUMONITIS DURING LOW-DOSE METHOTREXATE THERAPY [J].
MAIER, WP ;
LEONPEREZ, R ;
MILLER, SB .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (03) :602-603